National Scleroderma Foundation Inc logo

National Scleroderma Foundation Inc

Public charity · Grantmaker Danvers, MA EIN: 52-1375827 Website

The National Scleroderma Foundation's mission is to advance medical research, promote disease awareness, and provide support and education to people with scleroderma, their families and support networks.

National Scleroderma Foundation Inc at a glance

In short: National Scleroderma Foundation Inc gave $1.2M across 6 grants in 2025 (avg $200K), top state Connecticut. Source: 2025 IRS Form 990.

Annual giving (2025)
$1,199,988
-0.0% vs 2024
Grants made (2025)
6
+0.0% vs 2024
Average grant
$199,998
-0.0% vs 2024
Median grant
$199,998
Total assets
$11,259,408
+0.9% vs 2024
Primary geography
Connecticut (33% of itemized 2025 grant dollars)
Latest 990 filing
Form 990, 2025 View filing

Data from IRS Form 990, 2025; updated September 2026.

How to apply to National Scleroderma Foundation Inc

Who National Scleroderma Foundation Inc funds

How this funder distributes its grants

Top Recipients

Top 5 recipients in 2025

Yale University: $400K across 2 grantsYale University$400K · 2 grantsThe Regents of the University of Michigan: $200KThe Regents of the Universityof Michigan$200KUniversity of Washington: $200KUniversity of Washington$200KJohn Hopkins University: $200KJohn Hopkins University$200KTrustees of Dartmouth College: $200KTrustees of Dartmouth College$200K

The largest 2025 recipient was Yale University ($400K across 2 grants). Together the top 5 received $1.2M.

Grant Size Distribution

40 grants across all recorded years

1<$50K$50–100K39$100–250K$250–500K$500K–1M$1–5M$5M+

The most common grant size was in the $100–250K range: 39 grants of 40 (98%).

Geographic Focus

Where this funder awards grants

Grant Distribution by State

17states

Share of 2025 grant dollars across all 6 itemized grants.

Cities

PittsburghNew YorkBostonChicagoClevelandCharlestonNew HavenRochesterAlbuquerqueAnn ArborArlingtonBaltimoreDanversEl PasoHanoverHoustonKansas CityLa JollaLos AngelesMinneapolis

How National Scleroderma Foundation Inc gives

  • Giving fell 51% from 2022 to 2025. Method

From the foundation's IRS Form 990 filings. Methodology.

Giving History

Giving Over Time

Total grant dollars and number of grants per year

$0$1M$2M$3M8 grants2020 7 grants2021 13 grants2022 8 grants2023 6 grants2024 6 grants2025

From 2020 to 2025, annual grant giving ranged from $1.1M (2021) to $2.4M (2022). In 2025 it made 6 grants totaling $1.2M.

Grants by year

Grant recipients and amounts by year

RecipientPurposeAmount
The Regents of the University of Michigan Pittsburgh, PAResearch$199,998
Yale University New Haven, CTResearch$199,998
University of Washington Chicago, ILResearch$199,998
John Hopkins University Chicago, ILResearch$199,998
Yale University New Haven, CTResearch$199,998
Trustees of Dartmouth College Hanover, NHResearch$199,998
Your AI grants department

Ready to take the next step with National Scleroderma Foundation Inc?

Fully replaces Grant database subscriptions Instrumentl · Foundation Directory · GrantStation & similar

Financial History

Multi-year comparison from IRS filings

Figures from IRS filings, by filing year
Filing yearTotal AssetsRevenueExpensesGrants paidGrantsNet Investment Income
2025$11,259,408$6,628,652$6,783,274$1,199,9886$1,165,141
2024$11,162,466$4,941,722$6,956,852$1,200,0006$970,638
2023$12,897,422$6,915,898$6,461,742$1,600,0008$476,604
2022$11,463,074$4,581,467$6,210,712$2,425,00013$119,037
2021$13,492,271$4,188,631$4,468,676$1,050,0007$211,246
2020$11,612,013$3,811,707$5,012,061$1,200,0008$247,976

About National Scleroderma Foundation Inc

Based on IRS filings

National Scleroderma Foundation Inc is a public charity focused on Medical Research, based in Danvers, MA. IRS filing data is available from 2020 through 2025. As of 2025, the organization holds $11.3M in total assets. In 2025, it awarded 6 grants totaling $1.2M. Net investment income was $1.2M.

Focus Areas

Leadership & Key People

Officers and directors from IRS filings

National Scleroderma Foundation Inc is led by Mary J. Wheatley, CEO on every filing since 2022; 5 of 24 officers listed in 2025 are compensated.

Officers on the 2025 filing

  • Mary J. Wheatley

    CEO

    On filings since 2022

    37.5 hrs/week

    $101K (2022) → $253K (2025)

  • Kevin Boyanowski

    Chair

    Director → Chair, 2023

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Catherine M. Anastasia

    Senior Director & Mission Delivery

    New on the 2025 filing

    37.5 hrs/week

    $113K (2025)

  • Elizabeth J. Mulroy

    Senior Director & Chapter Operations

    New on the 2025 filing

    37.5 hrs/week

    $114K (2025)

  • Christina Loccke

    Director

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Cos Mallozzi

    Director

    Chair → Director, 2023

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Jane Ladas

    Director

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Mark Orozco III MBA

    Director

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Mary Blades

    Director

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Courtney Caliendo Esq.

    Director

    On filings since 2021

    2 hrs/week

    No compensation reported

  • Linda Bornstein Baum Od

    Director

    On filings since 2023

    2 hrs/week

    No compensation reported

  • Zeba Hyder

    Director

    On filings since 2023

    2 hrs/week

    No compensation reported

  • Aj Nahmad

    Director

    On filings since 2024

    2 hrs/week

    No compensation reported

  • J. Michael Levengood Esq.

    Director

    Secretary → Director, 2025

    On filings since 2024

    2 hrs/week

    No compensation reported

  • Nancy Waltermire

    Director

    On filings since 2024

    2 hrs/week

    No compensation reported

  • Peggy Collins

    Director

    New on the 2025 filing

    2 hrs/week

    No compensation reported

  • Scott Ceresnak MD

    Director

    New on the 2025 filing

    2 hrs/week

    No compensation reported

  • Tera Carter

    Director

    New on the 2025 filing

    2 hrs/week

    No compensation reported

  • Tracy Porter Med Sphr

    Director

    New on the 2025 filing

    2 hrs/week

    No compensation reported

  • Michael B. Hyde

    Vice President of Finance

    COO & CFO → Vice President of Finance, 2024

    On filings since 2021

    37.5 hrs/week

    $120K (2021) → $131K (2025)

  • Ashley M. Pruett

    Vice President of Community Engagement

    On filings since 2024

    37.5 hrs/week

    $128K (2024) → $144K (2025)

  • Marcia Walker

    Secretary

    Director → Secretary, 2025

    On filings since 2020

    2 hrs/week

    No compensation reported

  • Carol Feghali-Bostwick Ph D.

    Vice Chair

    On filings since 2023

    2 hrs/week

    No compensation reported

  • Blake Embree

    Treasurer

    On filings since 2024

    2 hrs/week

    No compensation reported

Former officers (11)
  • Former: Tracy Porter (2024) — Director
  • Former: Cyndy Besselievre CPA (2020–2023) — Treasurer
  • Former: Mike Levengood Esq. (2020–2023) — Secretary
  • Former: Jeanne Theissen (2022–2023) — Director
  • Former: Michael Pursel (2023) — Director
  • Former: Carol Feghali-Bostwick PhD (2020–2022) — Vice Chair
  • Former: Greg Marion (2020–2022) — Treasurer
  • Former: Linda Baum (2020–2022) — Director
  • Former: Robert J. Riggs (2020–2022) — CEO
  • Former: Mary Beth Tourbin (2020–2021) — Director
  • Former: Kerri Connolly (2021) — Nat. Director of Programs & Serv.

Data from IRS Form 990 filings, 2020–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.

Compensation Overview

From 2025 IRS filing

Mary J Wheatley — CEO: $253KMary J WheatleyCEO$253KAshley M Pruett — VP of Community Engagement: $144KAshley M PruettVP of Community Engagement$144KMichael B Hyde — VP of Finance: $131KMichael B HydeVP of Finance$131KElizabeth J Mulroy — Senior Director, Chapter Operations: $114KElizabeth J MulroySenior Director, Chapter…$114KCatherine M Anastasia — Senior Director, Mission Delivery: $113KCatherine M AnastasiaSenior Director, Mission…$113K

The highest reported compensation on the 2025 filing was $253K, to Mary J Wheatley (CEO). 5 officers or directors reported compensation on that filing.

Frequently asked questions about National Scleroderma Foundation Inc

How much does National Scleroderma Foundation Inc give each year?

National Scleroderma Foundation Inc gave $1.2M across 6 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $1.2M across 6 grants.

What is National Scleroderma Foundation Inc's typical grant size?

National Scleroderma Foundation Inc's median grant in 2025 was $199,998, and its average grant was $199,998, across 6 grants on its 2025 IRS Form 990.

Where does National Scleroderma Foundation Inc give grants?

National Scleroderma Foundation Inc's top state is Connecticut, with 33% of the grant dollars itemized on its 2025 IRS Form 990. The next largest states were Illinois (33%) and Pennsylvania (17%). The most frequent recipient cities were New Haven, CT (2 grants) and Chicago, IL (2 grants).

Does National Scleroderma Foundation Inc give general operating support?

Not in 2025: none of the 6 grants with a stated purpose on National Scleroderma Foundation Inc's 2025 IRS Form 990 were described as general or operating support. Recurring purposes include "Research" (6 grants).

Who are National Scleroderma Foundation Inc's largest grantees?

National Scleroderma Foundation Inc's largest 2025 grantees include Yale University ($399,996 across 2 grants), The Regents of the University of Michigan ($199,998) and University of Washington ($199,998), according to its 2025 IRS Form 990. Together they received 67% of its itemized 2025 grant dollars.

How large is National Scleroderma Foundation Inc?

National Scleroderma Foundation Inc reported $11.3M in total assets on its 2025 IRS Form 990. Its revenue that year was $6.6M.

What is National Scleroderma Foundation Inc?

National Scleroderma Foundation Inc is a public charity focused on Medical Research, based in Danvers, MA. It holds $11.3M in total assets as of 2025.

What is National Scleroderma Foundation Inc's EIN?

National Scleroderma Foundation Inc's EIN (Employer Identification Number) is 52-1375827. IRS Form 990 filing data is available on this page for 2020–2025.

Data last updated September 2026. Sourced from IRS Form 990 filings.

Data update history

(7)

When this profile's IRS filing data changed on Grantable

  1. Updated Form 990 for fiscal year 2020 (received by the IRS January 12, 2021)
  2. Updated Form 990 for fiscal year 2021 (received by the IRS January 27, 2022)
  3. Updated Form 990 for fiscal year 2022 (received by the IRS December 15, 2022)
  4. Updated Form 990 for fiscal year 2023 (received by the IRS January 18, 2024)
  5. Updated Form 990 for fiscal year 2024 (received by the IRS February 5, 2025)
  6. Updated Form 990 for fiscal year 2025 (received by the IRS February 18, 2026)
  7. IRS filings on file for fiscal years 2020–2025

Explore Open Grants

Browse active grant opportunities in National Scleroderma Foundation Inc's focus areas in our free grants database

Similar Funders

Funders that support many of the same organizations

Yale University

New Haven, CT

Yale University funds sponsored research, education and institutional programs, student aid, and charitable or community support, with 2025 grants ranging from $3,000 to $14.3 million and a median of about $136,000. Grants went to recipients in multiple states, with the largest shares in Connecticut, California, Massachusetts, New York, and Pennsylvania. The information does not state whether Yale accepts unsolicited requests.

Education

Assets

$58.9B

Grants

364

Total Given

$168.2M

Cystic Fibrosis Foundation

Bethesda, MD

The Cystic Fibrosis Foundation funds cystic fibrosis research, drug development, specialized care, and related training and clinical programs. In 2024, its grants had a median of about $150,000, with awards ranging from $2,800 to nearly $12.9 million; it supports work nationwide. Applications are submitted through specific funding opportunities, but the profile does not state whether unsolicited requests are accepted.

Diseases, Disorders & Medical Disciplines

Assets

$5.0B

Grants

624

Total Given

$189.6M

Drexel University

Philadelphia, PA

Drexel University’s reported grants primarily support research at universities, research organizations, and other institutions. In 2025, grants ranged from $5,125 to $2.21 million, with a median of about $63,000; recipients were concentrated in Pennsylvania, followed by California, Texas, Maryland, and New Jersey, with no stated geographic restriction. Its funding materials describe support for Drexel faculty and staff proposals, and do not state whether it accepts unsolicited requests.

Assets

$2.9B

Grants

120

Total Given

$16.9M

Johns Hopkins University

Baltimore, MD

Johns Hopkins University funds a broad range of education, research, health, and community-related work, with 2025 grants ranging from $5,500 to nearly $95 million and a median of $100,000; many of the largest awards were sub-awards. Its grants went to organizations across the U.S., with the largest shares in California and Maryland, and the profile does not state whether it accepts unsolicited requests.

Assets

$25.3B

Grants

813

Total Given

$594.1M

Seattle Children's Hospital

Seattle, WA

Seattle Children’s funds pediatric medical research, education, healthcare access, mental health and children’s health initiatives; its external Crossett Fund supports projects benefiting children and youth in Southeast Alaska. Its 2025 grants ranged from $5,326 to $15.3 million, with a median of $57,582, while Crossett awards are capped at $10,000. The Crossett Fund accepts applications year-round; other unsolicited requests are not described.

Assets

$6.0B

Grants

181

Total Given

$56.3M

American Heart Association Inc

Dallas, TX

The American Heart Association funds basic, clinical, behavioral, translational and population research on cardiovascular, cerebrovascular and brain health, along with research training and education programs. In 2025 it awarded 833 grants totaling about $198 million; amounts ranged from $5,000 to nearly $9.93 million, with a median of $20,000. Research awards are for eligible U.S.-based nonprofit institutions, and the profile describes a formal proposal process but does not state whether unsolicited requests are accepted.

Diseases, Disorders & Medical Disciplines

Assets

$2.0B

Grants

833

Total Given

$198.2M

More similar funders

More Funders in Massachusetts

The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open

Figures come from National Scleroderma Foundation Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.

National Scleroderma Foundation Inc down — hundreds of funders to go?

Want AI to do this for you?